New stem cell filter could reduce transplant rejection
NCT ID NCT03626285
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study offers a special stem cell transplant to people with cancer or other disorders who lack a perfectly matched donor. Doctors use a device to purify stem cells from a partially matched donor, removing immune cells that can cause rejection or attack the patient's body. The goal is to make the transplant safer and more effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CD34-selected peripheral blood stem cells
What this could lead to
If successful, this approach could make stem cell transplants safer and more available for patients who lack a perfectly matched donor.
What could go wrong
This is an early access protocol, not a controlled trial, so results are uncertain. Risks include graft failure, infection, and graft-versus-host disease despite the CD34 selection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
OHSU Knight Cancer Institute
AVAILABLEPortland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact